PubMed Health⌕ Search

PubMed · 14570212

Performance study of diffusive gradients in thin films for 55 elements.

Abstract

The technique of diffusive gradients in thin films (DGT) is a fairly new and useful tool for in situ measurements of labile metal ions in water. The applicability of DGTs was investigated by comparing independently determined or estimated diffusion coefficients with DGT effective diffusion coefficients (D(DGT)) for 55 elements. The DGTs were exposed at a controlled fluid velocity of 0.1 m s(-1) and a concentration of 1 ng mL(-1) at four pH levels between 4.7 and 6.0, and the D(DGT) values were determined from the uptake by the sampler. The measured D(DGT) values for the elements Co, Ni, Cu, Zn, Cd, Pb, Al, Mn, and Ga were close to previously published values with some deviations for Pb and Zn. The uptake of V, Cr, Fe, U, Mo, Ti, Ba, and Sr varied with pH, and there were some experimental problems that require further investigations. A novel set of D(DGT) values for the lanthanides (La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Tb, Yb, Lu, Y) was established. The D(DGT) values for these were about 10-15% lower than for free ions in water and indicate that diffusion coefficients of metal ions in the agarose polyacrylamide diffusive hydrogel are 10-15% lower than in water. The high consistency of the data for the lanthanides establishes these elements as new performance test metals for the DGT sampler. The accumulation of the elements Li, Na, K, Rb, Mg, Ca, B, Tl, P, S, As, Bi, Se, Si, Sn, Sb, Te, Zr, Nb, Hf, Ta, W, Th, and Ag was low (D(DGT) lower than 10% of theoretical values). A more efficient elution procedure using concentrated nitric acid for the absorbent gel was established, with elution efficiencies between 95 and 100% for most metals. For deployment times of 24 h, detection limits from 0.001 to 1 ng mL(-1) were achieved with moderate precautions to prevent contamination.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Oyvind Aaberg Garmo, Oddvar Røyset, Eiliv Steinnes, Trond Peder Flaten. 2003-07-15. Performance study of diffusive gradients in thin films for 55 elements.. https://doi.org/10.1021/ac026374n

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗